why choose us

First received: March 06, 2023

Clinical Trial: Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Biliary Tract Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase IIIb, Single Arm, Open-label, Multicentre Study of Durvalumab in Combination With Chemotherapy for the First Line Treatment for Patients With Advanced Biliary Tract Cancers (TOURMALINE)

Brief Summary: A study to assess the safety and efficacy of durvalumab in combination with gemcitabine-based chemotherapy regimens in participants with aBTC.

Read more